SCEMBLIX® (asciminib) tablets HCP

Scemblix® (asciminib) tablets hcp email format

Verified email-pattern data for Scemblix® (Asciminib) Tablets Hcp is currently limited. You can still use the company insights and contact sections below.
This information is for US health care professionals only. SCEMBLIX is a Novartis product and is not associated with any individual users on LinkedIn. Please see full Prescribing Information for SCEMBLIX at bit.ly/SCEMBPI. To report SUSPECTED ADVERSE REACTIONS, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 265985 3/23
Looking for a particular SCEMBLIX® (asciminib) tablets HCP employee's phone or email?

Scemblix® (Asciminib) Tablets Hcp Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant